100
Participants
Start Date
May 28, 2021
Primary Completion Date
October 31, 2025
Study Completion Date
December 31, 2026
Resin microspheres containing yttrium-90 (Y-90)
Biocompatible resin microspheres are an injectable permanent implant and preferentially placed into the distal microvascular supply of tumors to provide direct irradiation of tissue and destruction of the microvascular bed. Spheres contain yttrium-90 (Y-90) and are a size between 20 and 60 microns in diameter.
Columbia University CUIMC/NYPH, New York
Allegheny-Singer Research Institute, Pittsburgh
Hospital of the University Pennsylvania, Philadelphia
Wake Forest Baptist Health, Winston-Salem
University of North Carolina - Chapel Hill Medical Center, Chapel Hill
Emory University Hospital Midtown, Atlanta
Miami Cardiac and Vascular Institute at Baptist Hospital, Miami
Sarasota Memorial Health Care System, Sarasota
The Cleveland Clinic Foundation, Cleveland
University of Cincinnati Cancer Center CTO, Cincinnati
University of Kansas Medical Center, Kansas City
Clinical Research Institute and Methodist Hospital, Dallas
University of Texas Health Science Center at Houston, Houston
UT MD Anderson Cancer Center, Houston
University of California Los Angeles - Ronald Reagan Medical Center, Los Angeles
Providence St. Joseph Hospital, Orange
University of California Irvine, Orange
Inland Imaging, Spokane
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Rhode Island Hospital, Providence
The University of Vermont Medical Center, Burlington
Lead Sponsor
Bright Research Partners
INDUSTRY
Sirtex Medical
INDUSTRY